Business Context and Reporting Period
This Form 8-K was filed by ARTS WAY MANUFACTURING CO INC on January 9, 2012. The report covers events occurring between January 3, 2012, and January 9, 2012, primarily focusing on the Company's wholly-owned subsidiary, Art's-Way Scientific.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report serves as a notification of press releases and presentations rather than a financial statement.
- Revenue/Profit: No specific figures provided in the text.
- Cash Flow/Liquidity: No specific figures provided in the text.
- Debt: No specific figures provided in the text.
Material Changes and Events
The filing highlights several material events regarding the subsidiary, Art's-Way Scientific:
- Q4 Sales and Backlog: Press releases issued on January 3 and January 6, 2012, announced fourth-quarter sales and backlog growth (Exhibits 99.1 and 99.2).
- New Sales Contract: A press release issued on January 4, 2012, announced the procurement of a new sales contract (Exhibit 99.5).
- Conference Presentation: The Company presented at the Sidoti & Company, LLC Micro-Cap Conference on January 9, 2012, covering historical performance and growth opportunities (Exhibits 99.3 and 99.4).
Guidance, Outlook, and Risks
Management commentary regarding historical performance and growth opportunities was delivered during the January 9, 2012, conference presentation. The filing explicitly states that the information contained in the press releases and presentation slides is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. No specific forward-looking guidance numbers or risk factors are detailed in the body of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 and 99.2 for specific details on Q4 sales and backlog growth figures.
- Examine Exhibit 99.5 for terms and value of the new sales contract procured by Art's-Way Scientific.
- Analyze Exhibit 99.3 (Slide Presentation) for management's qualitative outlook and growth strategy.
- Note that the financial data referenced in the exhibits is not audited or "filed" under Section 18 liability standards.